Daily FNArena News

You are hereby invited to express your personal view on the share market. The survey takes up a few minutes only – and it closes midnight today!

Bionomics has moved into the cancer stem cell field through a US acquisition and on the news Bell Potter reiterates its Buy rating for the stock.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Morgan Stanley sees the potential for the ASX to downgrade its FY13 earnings outlook at its AGM.

Weekly update on recommendation, target price, and earnings forecast changes.

Silex Systems is developing laser-based uranium enrichment technology and the company has received good news with a licence for a proposed plant being recommended by US regulators.

This week’s Tweets on Twitter by Your Editor.

Market analysts at FXCM suggest gold’s recent consolidation may form a short-term bullish triange, which indicates an upside breakout.

Peter Switzer of the Switzer Super Report reveals his preferred mining services stock.

The latest surveys by Barclays and Merrill Lynch show investor confidence is improving, with equities and commodities among preferred asset classes and Europe becoming less of an issue.

Analysis by Moelis suggests the current share price premium to peers enjoyed by WorleyParsons is difficult to justify, the broker reiterating its Sell rating on the stock.